Let's be clear. There have been some bad actors among some pharmaceutical company executives who have abused market power in some situations. There are notorious examples of this. With respect, however, they are not necessarily representative of all of the companies by any stretch of the imagination.
I'm going to offer an analogy, and it may make some people uncomfortable. There have been allegations of parliamentarians not having appropriate behaviours towards certain of their staff. That isn't to say that every one of you on this committee is a sexual predator.
Yes, there can be bad actors and they deserve to be taken to task, and I think there are ways and means of doing that. On the other hand, I think some of the criticism comes from a point of view [Technical difficulty—Editor] do not have regard for—I will say it—a commercial business or profit-seeking motive. There are patients who share that value judgment, and there are patients who come from among senior business executives—